IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xainli, J.
Right arrow Articles by King, C. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xainli, J.
Right arrow Articles by King, C. L.

 Previous Article  |  Next Article 

Infection and Immunity, May 2003, p. 2508-2515, Vol. 71, No. 5
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.5.2508-2515.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Epitope-Specific Humoral Immunity to Plasmodium vivax Duffy Binding Protein

Jia Xainli,1 Jennifer L. Cole-Tobian,1,2 Moses Baisor,3 Will Kastens,1 Moses Bockarie,3 Syed Shams Yazdani,4 Chetan E. Chitnis,4 John H. Adams,5 and Christopher L. King1,2*

Center for Global Health and Diseases, Case Western Reserve University,1 Veterans Affairs Medical Center, Cleveland, Ohio,2 Papua New Guinea Institute of Medical Research, Madang, Papua New Guinea,3 International Centre for Genetic Engineering and Biotechnology, New Delhi, India,4 Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana5

Received 30 September 2002/ Returned for modification 19 November 2002/ Accepted 10 February 2003

Erythrocyte invasion by Plasmodium vivax is completely dependent on binding to the Duffy blood group antigen by the parasite Duffy binding protein (DBP). The receptor-binding domain of this protein lies within a cysteine-rich region referred to as region II (DBPII). To examine whether antibody responses to DBP correlate with age-acquired immunity to P. vivax, antibodies to recombinant DBP (rDBP) were measured in 551 individuals residing in a village endemic for P. vivax in Papua New Guinea, and linear epitopes mapped in the critical binding region of DBPII. Antibody levels to rDBPII increased with age. Four dominant linear epitopes were identified, and the number of linear epitopes recognized by semiimmune individuals increased with age, suggesting greater recognition with repeated infection. Some individuals had antibodies to rDBPII but not to the linear epitopes, indicating the presence of conformational epitopes. This occurred in younger individuals or subjects acutely infected for the first time with P. vivax, indicating that repeated infection is required for recognition of linear epitopes. All four dominant B-cell epitopes contained polymorphic residues, three of which showed variant-specific serologic responses in over 10% of subjects examined. In conclusion, these results demonstrate age-dependent and variant-specific antibody responses to DBPII and implicate this molecule in partial acquired immunity to P. vivax in populations in endemic areas.


* Corresponding author. Mailing address: Center for Global Health and Diseases, Rm. 137, Case Western Reserve University, 2109 Adelbert Rd., Cleveland, OH 44106-4983. Phone: (216) 368-4817. Fax: (216) 368-4825. E-mail: cxk21{at}po.cwru.edu.

Editor: S. H. E. Kaufmann


Infection and Immunity, May 2003, p. 2508-2515, Vol. 71, No. 5
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.5.2508-2515.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2003 by the American Society for Microbiology. All rights reserved.